Share
15,643 Posts.
lightbulb Created with Sketch. 5711
clock Created with Sketch. 27/10/21
13:16
Share
Originally posted by stockrock
↑
After a seemingly quiet period for Mesoblast... it is going to change rather quickly IMO.
Expand
Don't think for a second that Novartis hasn't helped MSB with these potency assays and passed on their learnings on how to deal with the FDA and OTAT.. and don't think the FDA are not aware Novartis are waiting on the wings. @stockrock ... and of course because Novartis have signed the initial collaboration agreement for Remestemcel-L they would be entitled to be present at the OTAT meeting
(20min delay)